Abstract:AIM: To study the significance of p16 and p15 transcription suppression with hypermethylation of their genes' 5' CpG islands during human hepatocellular carcinogenesis.METHODS: The mRNA expression levels of p16 and p15 genes were evaluated in cancerous, para-cancerous and non-cancerous tissues of 20 HCC, 3 normal liver tissues from 3 accidentally died healthy adults using semi-quantitatively Northern blot. The methylation status was also assessed with methylation specific PCR.RESULTS: p16 mRNA expression level was decreased in the cancerous tissues in 60% (12/20) of HCC patients, of which 2 cases had no p16 mRNA detected, 5 cases (25%) displayed variation in the order of cancerous<paracancerous<non-cancerous liver tissues. p15 mRNA expression level was decreased in the cancerous tissues in 50% (10/20) HCC patients, of which one case had no p15 mRNA detected, 4 cases (20%) displayed variation in the order of cancerous<para-cancerous<non-cancerous liver tissues. In cancerous, para-cancerous and non-cancerous tissues, p16 promoter CpG islands hypermethylation occurred 65%, 60% and 35%, while p15 promoter CpG islands hypermethylation occurred 50%, 40% and 25%. Of 12 HCCs with lower p16 mRNA expression level, 11 cases showed p16 promoter CpG islands methylation (91.6%). Hundred percent (10/10) HCCs with lower p15 mRNA expression level showed p15 promoter CpG islands methylation. Significant correlation between 5' CpG islands methylation and p16/p15 mRNA expression suppression was found. The decreased expression of p16/p15 mRNA or methylation of p16/p15 promoters 5' CpG island was significantly correlate with poor differentiation of HCC (P=0.0083, 0.0102, 0.00271, 0.0218, respectively, P<0.05).CONCLUSION: p16 and p15 genes transcriptional inactivation might play an important role in hepatocarcinogenesis. 5' CpG islands methylation might be the major mechanism of p16 and p15 genes inactivation in primary HCC in the studied population. 5' CpG islands methylation of p16 and p15 genes might be an early event in hepatocarcinogenesis.

Homozygous deletion of p16 and p15 genes in laryngeal squamous cell carcinoma]

Association of Homozygous Deletion of p15 and p16 Gene and Amplification of EGFR Gene in Laryngeal Squamous Cell Carcinoma

Deletion of p15 and p16 genes and overexpression of STK15 gene in human laryngeal squamous cell carcinoma]

Deletion of P16 gene exon 2 in bronchofibroscopic brush-off cells of human lung carcinoma

Detection of p16 gene deletion and methylation in esophageal squamous cell carcinoma tissue

Homozygous deletion of p15、 p16 genes in lung cancer

Methylation and expression of p16INK4a gene in laryngeal squamous cell carcinomas

[Expression of P15 and P16 Proteins in Tongue Squamous Cell Carcinoma and Their Significances].

Mutation of P53 and Overexpression of STK15 in Laryngeal Squamous-Cell Carcinoma

Abnormalities of Tumor Suppressor Genes P16 and P15 in Primary Maxillofacial Squamous Cell Carcinomas

Infrequent Mutations and No Methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/mts2) in Hepatocellular Carcinoma in Taiwan.

[The Relationship of P53 Gene Mutation to Cell Differentiation and Metastasis of Laryngeal Squamous Cell Carcinoma].

Expression of p16 and Ki67 in laryngeal squamous cell carcinoma and their clinical significance

[Mutation Analysis of P16 Gene in Non-Small Cell Lung Carcinomas].

Overexpression of CyclinD1 and Underexpression of P16 Correlate with Lymph Node Metastases in Laryngeal Squamous Cell Carcinoma in Chinese Patients

Association of Low P16ink4a and P15ink4b Mrnas Expression with Their Cpg Islands Methylation with Human Hepatocellular Carcinogenesis

Study on Correlation Between the Mutation and Expression of P16 Gene and Laryneal Cancer

[Expression of Six Gene Proteins in Laryngeal Carcinomas and Their Significance].

The Relationship Between P16 Expression and Clinicalpathology of Laryngeal Squamous Cell Carcinoma

Clinical significance of p15 gene deletions in esophageal cancer

[The Changes and Significance of Microsatellite Loss of Heterozygosity in Laryngeal Premalignant Lesions and Squamous Cell Carcinoma].